News

Barbara Milczarek for The World of Pharmaceutical Industry Magazine!

In order to patent a new chemical compound, which is to be used for medical purposes, it is necessary to present already in the patent application the results of a research confirming its therapeutic effects.

In the latest issue of the magazine “The World of Pharmaceutical Industry” (“Świat Przemysłu Farmaceutycznego”) Barbara Milczarek, a patent attorney at Patpol, discussed the obligation of a sufficient disclosure of invention in the context of the application procedures.

We invite you to read the full article in polish.


dr Katarzyna Jedynak on Life Sciences IP Summit in Munich!

Life Sciences IP Summit, which is an international meeting of patent attorneys dealing on a Czytaj dalej

Dariusz Świerczyński on International Conference of the Household Chemical Industry

Industry will be held for the tenth time, organized by the publisher of the Chemia Czytaj dalej